Recurrent spontaneous miscarriages and hyperhomocysteinemia;Aborti spontanei ricorrenti e iperomocisteinemia

Minerva Ginecologica

Volumn 56, Issue 5, 2004, Pages 379-383

  Del Bianco, A ^a,b   Maruotti, G ^a   Fulgieri, A M ^a   Celeste, T ^a   Lombardi, L ^a   Amato, N A ^a   Pietropaolo, F ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b NONE   (Italy)

Author keywords

Abortion, spontaneous, diagnosis; Abortion, spontaneous, etiology; Hyperhomocysteinemia

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FETUS WASTAGE; FOLATE METABOLISM; FOLIC ACID DEFICIENCY; GESTATIONAL AGE; HUMAN; HYPERHOMOCYSTEINEMIA; PATHOPHYSIOLOGY; RECURRENT ABORTION; RISK ASSESSMENT; RISK FACTOR; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ADULT; CASE-CONTROL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST;

EID: 11144310077     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Carp H, Dolitzky M, Inbal A. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. J Thromb Haemost 2003;1:433-8.
2. Brenner B. Inherited thrombophilia and pregnancy loss. Best Pract Res Clin Haematol 2003;16:311-20.
3. Villarreal C, Garcia-Aguirre G, Hernandez C, Vega O, Borbolla JR, Collados MT. Congenital thrombophilia associated to obstetric complications. J Thromb Thrombolysis 2002;14:163-9.
4. Brenner B. Thrombophilia and fetal loss. Semin Thromb Hemost 2003;29;165-70.
5. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003;361:901-8.
6. Adelberg AM, Kuller JA. Thrombophilias and recurrent miscarriage. Obstet Gynecol Surv 2002;57:703-9.
7. Regan L, Rai R. Thrombophilia and pregnancy loss. J Reprod Immunol 2002;55:163-80.
8. Saade GR, McLintock C. Inherited thrombophilia and stillbirth. Semin Perinatol 2002;26:51-69.
9. Sarig G, Younis JS, Hoffman R, Lanir N, Blumenfeld Z, Brenner B. Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril 2002;77:342-7.
10. Pathare A, al Kindi S, al Belushi T, Bayoumi R, Dennison D, Murlitharan S. Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis. Haematologia (Budap) 2002;32:551-6.
11. Martinelli I, Battaglioli T, Pedotti P, Cattaneo M, Mannucci PM. Hyperhomocysteinemia in cerebral vein thrombosis. Blood 2003;102:1363-6.
12. Keijzer MB, den Heijer M, Blom HJ, Bos GM, Willems HP, Gerrits WB et al. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolate- reductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis. Thromb Haemost 2002;88:723-8.
13. Key NS, McGlennen RC. Hyperhomocyst(e)inemia and Thrombophilia. Arch Pathol Lab Med 2002;126:1367-75.
14. Yap S. Classical homocystinuria: vascular risk and its prevention. J Inherit Metab Dis 2003;26:259-65.
15. Meier M, Oliveriusova J, Kraus JP, Burkhard P. Structural insights into mutations of cystathionine beta-synthase. Biochim Biophys Acta 2003;1647:206-13.
16. Zavadakova P, Fowler B, Zeman J, Suormala T, Pristoupilova K, Kozich V et al. CblE type of homocystinuria due to methionine synthase reductase deficiency: clinical and molecular studies and prenatal diagnosis in two families. J Inherit Metab Dis 2002;25:461-76. Erratum in: J Inherit Metab Dis 2003;26:95.
17. Zavadakova P, Fowler B, Zeman J, Suormala T, Pristoupilova K, Kozich V et al. CblE type of homocystinuria due to methionine synthase reductase deficiency: clinical and molecular studies and prenatal diagnosis in two families. J Inherit Metab Dis 2002;25:461-76. Erratum in: J Inherit Metab Dis 2003;26:95.
18. Rodriguez-Esparragon F, Hernandez-Perera O, Rodriguez-Perez JC, Anabitarte A, Diaz-Cremades JM, Losada A et al. The effect of methylenetetrahydrofolate reductase C677T common variant on hypertensive risk is not solely explained by increased plasma homocysteine values. Clin Exp Hypertens 2003;25:209-20.
19. Herrmann W, Obeid R, Schorr H, Zarzour W, Geisel J. Homocysteine, ethylenetetrahydrofolate reductase C677T polymorphism and the B-vitamins: a facet of nature-nurture interplay. Clin Chem Lab Med 2003; 41:547-53.
20. Kumar KS, Govindaiah V, Naushad SE, Devi RR, Jyothy A. Plasma homocysteine levels correlated to interactions between folate status and methylene tetrahydrofolate reductase gene mutation in women with unexplained recurrent pregnancy loss. J Obstet Gynaecol 2003;23: 55-8.
21. Handy DE, Loscalzo J. Homocysteine and atherothrombosis: diagnosis and treatment. Curr Atheroscler Rep 2003;5:276-83.
22. Ingrosso D, Cimmino A, Perna AF, Masella L, De Santo NG, De Bonis ML et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 2003;361:1693-9.
23. Girelli D, Martinelli N, Pizzolo F, Friso S, Olivieri O, Stranieri C et al. The interaction between MTHFR 677 C>T genotype and folate status is a determinant of coronary atherosclerosis risk. J Nutr 2003;133: 1281-5.
24. Villarreal C, Garcia-Aguirre G, Hernandez C, Vega O, Borbolla JR, Collados MT. Congenital thrombophilia associated to obstetric complications. J Thromb Thrombolysis 2002;14:163-9.
25. Hague WM. Homocysteine and pregnancy. Best Pract Res Clin Obstet Gynaecol 2003;17:459-69.
26. Eskes TK. Clotting disorders and placental abruption: homocysteine: a new risk factor. Eur J Obstet Gynecol Reprod Biol 2001;95:206-12.
27. Wang J, Trudinger BJ, Duarte N, Wilcken DE, Wang XL. Elevated circulating homocyst(e)ine levels in placental vascular disease and associated pre-eclampsia. BJOG 2000;107:935-8.
28. Eskes TK. Homocysteine and human reproduction. Clin Exp Obstet Gynecol 2000;27:157-67.
29. Meedges BH, Inegnhoes R, Peeters LL, Exalto N. Early pregnancy wastage: relationship between chorionic vascularization and embryonic development. Fertil Steril 1988;49:216-20.
30. Steegers-Theunissen RP, Boers GH, Trijbels FJ, Eskes TK. Neural-tube defects and derangement of homocysteine metabolism. N Engl J Med 1991;324: 199-200.
31. Byrne J, Warburton D. Neural tube defects in spontaneous abortions. Am J Gent 1986;25:327-33.
32. Boers GHJ. The clinical usefulness of homocysteine determinations. In: Smith U, Eriksson S, Lindgarde S, editors. Genetic susceptibility to environmental factors. A challenge for public intervention. Stockolm: Almquist & Wiksell International, 1988.p.35-42.
33. Wouters MG, Boers GH, Blom HJ, Trijbels FJ, Thomas CM, Borm GF et al. Hyperomocysteinemia: a risk factor in women with enexpleined recurrent early pregnancy loss. Fert Steril 1993;60:820-5.
34. Quere I, Bellet H, Hoffet M, Janbon C, Mares P, Gris JC. A woman with five consecutive fetal deaths: a case report and retrospective analysis of hyperhomocysteinemia prevalence in 100 consecutive women with recurrent miscarriages. Fert Steril 1998;69:152-4.
35. Hibbard BM. The role of folic acid in pregnancy, with particulare refernce to anaemia, abruption and abortion. J Obstet Gynaecol Br Commonw 1964;71:529-42.